Matias Hannuksela1, Eva-Lena Stattin2, Bengt Johansson3, Bo Carlberg3. 1. Department of Surgical and Perioperative Science, Heart Centre, Umeå University , Umeå , Sweden. 2. Department of Medical Biosciences, Medical and Clinical Genetics, Umeå University , Umeå , Sweden. 3. Department of Public Health and Clinical Medicine, Umeå University , Umeå , Sweden.
Abstract
BACKGROUND: About 20% of patients with thoracic aortic aneurysm or dissection (TAAD) have a first-degree relative with a similar disease. The familial form (FTAAD) of the disease is inherited in an autosomal-dominant pattern. Current guidelines for thoracic aortic disease recommend screening of first-degree relatives of TAAD patients. In known familial disease, screening of both first- and second-degree relatives is recommended. However, the outcomes of such a screening program are unknown. METHODS: We screened all first- and second-degree relatives in seven families with known FTAAD with echocardiography. No underlying gene defect had been detected in these families. RESULTS: Of 119 persons investigated, 13 had known thoracic aortic disease. In the remaining 106 cases, we diagnosed 19 additional individuals with a dilated ascending thoracic aorta; for an autosomal-dominant disease, the expected number of individuals in this group would have been 40 (p<0.0001). Further, only one of the 20 first-degree relatives younger than 40 years had a dilated aorta, although the expected number of individuals with a disease-causing mutation would have been 10. CONCLUSIONS: In most families with TAAD, a diagnosis still relies on measuring the diameter of the thoracic aorta. We show that a substantial number of previously unknown cases of aortic dilatation can be identified by screening family members. It is, however, not possible to consider anyone free of the condition, even if the aortic diameter is normal, especially at a younger age.
BACKGROUND: About 20% of patients with thoracic aortic aneurysm or dissection (TAAD) have a first-degree relative with a similar disease. The familial form (FTAAD) of the disease is inherited in an autosomal-dominant pattern. Current guidelines for thoracic aortic disease recommend screening of first-degree relatives of TAAD patients. In known familial disease, screening of both first- and second-degree relatives is recommended. However, the outcomes of such a screening program are unknown. METHODS: We screened all first- and second-degree relatives in seven families with known FTAAD with echocardiography. No underlying gene defect had been detected in these families. RESULTS: Of 119 persons investigated, 13 had known thoracic aortic disease. In the remaining 106 cases, we diagnosed 19 additional individuals with a dilated ascending thoracic aorta; for an autosomal-dominant disease, the expected number of individuals in this group would have been 40 (p<0.0001). Further, only one of the 20 first-degree relatives younger than 40 years had a dilated aorta, although the expected number of individuals with a disease-causing mutation would have been 10. CONCLUSIONS: In most families with TAAD, a diagnosis still relies on measuring the diameter of the thoracic aorta. We show that a substantial number of previously unknown cases of aortic dilatation can be identified by screening family members. It is, however, not possible to consider anyone free of the condition, even if the aortic diameter is normal, especially at a younger age.
Authors: Loren F Hiratzka; George L Bakris; Joshua A Beckman; Robert M Bersin; Vincent F Carr; Donald E Casey; Kim A Eagle; Luke K Hermann; Eric M Isselbacher; Ella A Kazerooni; Nicholas T Kouchoukos; Bruce W Lytle; Dianna M Milewicz; David L Reich; Souvik Sen; Julie A Shinn; Lars G Svensson; David M Williams Journal: Circulation Date: 2010-03-16 Impact factor: 29.690
Authors: Christian Olsson; Carl-Gustaf Hillebrant; Jan Liska; Ulf Lockowandt; Per Eriksson; Anders Franco-Cereceda Journal: Ann Thorac Surg Date: 2011-08-19 Impact factor: 4.330
Authors: P G Hagan; C A Nienaber; E M Isselbacher; D Bruckman; D J Karavite; P L Russman; A Evangelista; R Fattori; T Suzuki; J K Oh; A G Moore; J F Malouf; L A Pape; C Gaca; U Sechtem; S Lenferink; H J Deutsch; H Diedrichs; J Marcos y Robles; A Llovet; D Gilon; S K Das; W F Armstrong; G M Deeb; K A Eagle Journal: JAMA Date: 2000-02-16 Impact factor: 56.272
Authors: Patric Biaggi; Felix Matthews; Julia Braun; Valentin Rousson; Philipp A Kaufmann; Rolf Jenni Journal: J Am Soc Echocardiogr Date: 2009-05-07 Impact factor: 5.251
Authors: Anne E Davis; Adam J Lewandowski; Cameron J Holloway; Ntobeko A B Ntusi; Rajarshi Banerjee; Richard Nethononda; Alex Pitcher; Jane M Francis; Saul G Myerson; Paul Leeson; Tim Donovan; Stefan Neubauer; Oliver J Rider Journal: J Cardiovasc Magn Reson Date: 2014-01-21 Impact factor: 5.364
Authors: Lidia R Bons; Allard T van den Hoven; Ayda E Damirchi; Denise van der Linde; Silvy Dekker; Robert M Kauling; Ingrid M B H van de Laar; Elisabeth M W J Utens; Ricardo P J Budde; Jolien W Roos-Hesselink Journal: Am J Med Genet A Date: 2019-05-27 Impact factor: 2.802
Authors: Alexander J Fletcher; Maaz B J Syed; Timothy J Aitman; David E Newby; Niki L Walker Journal: Circulation Date: 2020-05-11 Impact factor: 29.690